Global T-cells Leukemia Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 99 pages | ID: GDBD93E8E721EN
QYResearch

Abstracts

This report focuses on the global T-cells Leukemia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the T-cells Leukemia Treatment development in North America, Europe and Asia-Pacific.

The key players covered in this study

• BioCryst Pharmaceuticals
• Celgene
• GlaxoSmithKline
• Kirin Holdings
• Otsuka Holdings
• Mundipharma International
• Novartis

Market segment by Type, the product can be split into

• Surgery
• Chemotherapy
• Radiation Therapy

Market segment by Application, split into

• Hospitals
• Clinic
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• Asia-Pacific

The study objectives of this report are:

• To analyze global T-cells Leukemia Treatment status, future forecast, growth opportunity, key market and key players.
• To present the T-cells Leukemia Treatment development in North America, Europe and Asia-Pacific.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of T-cells Leukemia Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by T-cells Leukemia Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global T-cells Leukemia Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Surgery
  1.4.3 Chemotherapy
  1.4.4 Radiation Therapy
1.5 Market by Application
  1.5.1 Global T-cells Leukemia Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinic
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): T-cells Leukemia Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the T-cells Leukemia Treatment Industry
    1.6.1.1 T-cells Leukemia Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and T-cells Leukemia Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for T-cells Leukemia Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 T-cells Leukemia Treatment Market Perspective (2015-2026)
2.2 T-cells Leukemia Treatment Growth Trends by Regions
  2.2.1 T-cells Leukemia Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 T-cells Leukemia Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 T-cells Leukemia Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 T-cells Leukemia Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key T-cells Leukemia Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top T-cells Leukemia Treatment Players by Market Size
  3.1.1 Global Top T-cells Leukemia Treatment Players by Revenue (2015-2020)
  3.1.2 Global T-cells Leukemia Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global T-cells Leukemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global T-cells Leukemia Treatment Market Concentration Ratio
  3.2.1 Global T-cells Leukemia Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by T-cells Leukemia Treatment Revenue in 2019
3.3 T-cells Leukemia Treatment Key Players Head office and Area Served
3.4 Key Players T-cells Leukemia Treatment Product Solution and Service
3.5 Date of Enter into T-cells Leukemia Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global T-cells Leukemia Treatment Historic Market Size by Type (2015-2020)
4.2 Global T-cells Leukemia Treatment Forecasted Market Size by Type (2021-2026)

5 T-CELLS LEUKEMIA TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global T-cells Leukemia Treatment Market Size by Application (2015-2020)
5.2 Global T-cells Leukemia Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America T-cells Leukemia Treatment Market Size (2015-2020)
6.2 T-cells Leukemia Treatment Key Players in North America (2019-2020)
6.3 North America T-cells Leukemia Treatment Market Size by Type (2015-2020)
6.4 North America T-cells Leukemia Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe T-cells Leukemia Treatment Market Size (2015-2020)
7.2 T-cells Leukemia Treatment Key Players in Europe (2019-2020)
7.3 Europe T-cells Leukemia Treatment Market Size by Type (2015-2020)
7.4 Europe T-cells Leukemia Treatment Market Size by Application (2015-2020)

8 ASIA-PACIFIC

8.1 Asia-Pacific T-cells Leukemia Treatment Market Size (2015-2020)
8.2 T-cells Leukemia Treatment Key Players in Asia-Pacific (2019-2020)
8.3 Asia-Pacific T-cells Leukemia Treatment Market Size by Type (2015-2020)
8.4 Asia-Pacific T-cells Leukemia Treatment Market Size by Application (2015-2020)
(2015-2020)
(2015-2020)

9 KEY PLAYERS PROFILES

9.1 BioCryst Pharmaceuticals
  9.1.1 BioCryst Pharmaceuticals Company Details
  9.1.2 BioCryst Pharmaceuticals Business Overview and Its Total Revenue
  9.1.3 BioCryst Pharmaceuticals T-cells Leukemia Treatment Introduction
  9.1.4 BioCryst Pharmaceuticals Revenue in T-cells Leukemia Treatment Business (2015-2020))
  9.1.5 BioCryst Pharmaceuticals Recent Development
9.2 Celgene
  9.2.1 Celgene Company Details
  9.2.2 Celgene Business Overview and Its Total Revenue
  9.2.3 Celgene T-cells Leukemia Treatment Introduction
  9.2.4 Celgene Revenue in T-cells Leukemia Treatment Business (2015-2020)
  9.2.5 Celgene Recent Development
9.3 GlaxoSmithKline
  9.3.1 GlaxoSmithKline Company Details
  9.3.2 GlaxoSmithKline Business Overview and Its Total Revenue
  9.3.3 GlaxoSmithKline T-cells Leukemia Treatment Introduction
  9.3.4 GlaxoSmithKline Revenue in T-cells Leukemia Treatment Business (2015-2020)
  9.3.5 GlaxoSmithKline Recent Development
9.4 Kirin Holdings
  9.4.1 Kirin Holdings Company Details
  9.4.2 Kirin Holdings Business Overview and Its Total Revenue
  9.4.3 Kirin Holdings T-cells Leukemia Treatment Introduction
  9.4.4 Kirin Holdings Revenue in T-cells Leukemia Treatment Business (2015-2020)
  9.4.5 Kirin Holdings Recent Development
9.5 Otsuka Holdings
  9.5.1 Otsuka Holdings Company Details
  9.5.2 Otsuka Holdings Business Overview and Its Total Revenue
  9.5.3 Otsuka Holdings T-cells Leukemia Treatment Introduction
  9.5.4 Otsuka Holdings Revenue in T-cells Leukemia Treatment Business (2015-2020)
  9.5.5 Otsuka Holdings Recent Development
9.6 Mundipharma International
  9.6.1 Mundipharma International Company Details
  9.6.2 Mundipharma International Business Overview and Its Total Revenue
  9.6.3 Mundipharma International T-cells Leukemia Treatment Introduction
  9.6.4 Mundipharma International Revenue in T-cells Leukemia Treatment Business (2015-2020)
  9.6.5 Mundipharma International Recent Development
9.7 Novartis
  9.7.1 Novartis Company Details
  9.7.2 Novartis Business Overview and Its Total Revenue
  9.7.3 Novartis T-cells Leukemia Treatment Introduction
  9.7.4 Novartis Revenue in T-cells Leukemia Treatment Business (2015-2020)
  9.7.5 Novartis Recent Development

10 ANALYST'S VIEWPOINTS/CONCLUSIONS

11 APPENDIX

11.1 Research Methodology
  11.1.1 Methodology/Research Approach
  11.1.2 Data Source
11.2 Disclaimer
11.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. T-cells Leukemia Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by T-cells Leukemia Treatment Revenue
Table 3. Ranking of Global Top T-cells Leukemia Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global T-cells Leukemia Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Surgery
Table 6. Key Players of Chemotherapy
Table 7. Key Players of Radiation Therapy
Table 8. COVID-19 Impact Global Market: (Four T-cells Leukemia Treatment Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for T-cells Leukemia Treatment Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for T-cells Leukemia Treatment Players to Combat Covid-19 Impact
Table 13. Global T-cells Leukemia Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global T-cells Leukemia Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global T-cells Leukemia Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global T-cells Leukemia Treatment Market Share by Regions (2015-2020)
Table 17. Global T-cells Leukemia Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global T-cells Leukemia Treatment Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. T-cells Leukemia Treatment Market Growth Strategy
Table 23. Main Points Interviewed from Key T-cells Leukemia Treatment Players
Table 24. Global T-cells Leukemia Treatment Revenue by Players (2015-2020) (Million US$)
Table 25. Global T-cells Leukemia Treatment Market Share by Players (2015-2020)
Table 26. Global Top T-cells Leukemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T-cells Leukemia Treatment as of 2019)
Table 27. Global T-cells Leukemia Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players T-cells Leukemia Treatment Product Solution and Service
Table 30. Date of Enter into T-cells Leukemia Treatment Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global T-cells Leukemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 33. Global T-cells Leukemia Treatment Market Size Share by Type (2015-2020)
Table 34. Global T-cells Leukemia Treatment Revenue Market Share by Type (2021-2026)
Table 35. Global T-cells Leukemia Treatment Market Size Share by Application (2015-2020)
Table 36. Global T-cells Leukemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. Global T-cells Leukemia Treatment Market Size Share by Application (2021-2026)
Table 38. North America Key Players T-cells Leukemia Treatment Revenue (2019-2020) (Million US$)
Table 39. North America Key Players T-cells Leukemia Treatment Market Share (2019-2020)
Table 40. North America T-cells Leukemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. North America T-cells Leukemia Treatment Market Share by Type (2015-2020)
Table 42. North America T-cells Leukemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. North America T-cells Leukemia Treatment Market Share by Application (2015-2020)
Table 44. Europe Key Players T-cells Leukemia Treatment Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players T-cells Leukemia Treatment Market Share (2019-2020)
Table 46. Europe T-cells Leukemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. Europe T-cells Leukemia Treatment Market Share by Type (2015-2020)
Table 48. Europe T-cells Leukemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. Europe T-cells Leukemia Treatment Market Share by Application (2015-2020)
Table 50. Asia-Pacific Key Players T-cells Leukemia Treatment Revenue (2019-2020) (Million US$)
Table 51. Asia-Pacific Key Players T-cells Leukemia Treatment Market Share (2019-2020)
Table 52. Asia-Pacific T-cells Leukemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Asia-Pacific T-cells Leukemia Treatment Market Share by Type (2015-2020)
Table 54. Asia-Pacific T-cells Leukemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Asia-Pacific T-cells Leukemia Treatment Market Share by Application (2015-2020)
Table 56. BioCryst Pharmaceuticals Company Details
Table 57. BioCryst Pharmaceuticals Business Overview
Table 58. BioCryst Pharmaceuticals Product
Table 59. BioCryst Pharmaceuticals Revenue in T-cells Leukemia Treatment Business (2015-2020) (Million US$)
Table 60. BioCryst Pharmaceuticals Recent Development
Table 61. Celgene Company Details
Table 62. Celgene Business Overview
Table 63. Celgene Product
Table 64. Celgene Revenue in T-cells Leukemia Treatment Business (2015-2020) (Million US$)
Table 65. Celgene Recent Development
Table 66. GlaxoSmithKline Company Details
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Product
Table 69. GlaxoSmithKline Revenue in T-cells Leukemia Treatment Business (2015-2020) (Million US$)
Table 70. GlaxoSmithKline Recent Development
Table 71. Kirin Holdings Company Details
Table 72. Kirin Holdings Business Overview
Table 73. Kirin Holdings Product
Table 74. Kirin Holdings Revenue in T-cells Leukemia Treatment Business (2015-2020) (Million US$)
Table 75. Kirin Holdings Recent Development
Table 76. Otsuka Holdings Company Details
Table 77. Otsuka Holdings Business Overview
Table 78. Otsuka Holdings Product
Table 79. Otsuka Holdings Revenue in T-cells Leukemia Treatment Business (2015-2020) (Million US$)
Table 80. Otsuka Holdings Recent Development
Table 81. Mundipharma International Company Details
Table 82. Mundipharma International Business Overview
Table 83. Mundipharma International Product
Table 84. Mundipharma International Revenue in T-cells Leukemia Treatment Business (2015-2020) (Million US$)
Table 85. Mundipharma International Recent Development
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Product
Table 89. Novartis Revenue in T-cells Leukemia Treatment Business (2015-2020) (Million US$)
Table 90. Novartis Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global T-cells Leukemia Treatment Market Share by Type: 2020 VS 2026
Figure 2. Surgery Features
Figure 3. Chemotherapy Features
Figure 4. Radiation Therapy Features
Figure 5. Global T-cells Leukemia Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. T-cells Leukemia Treatment Report Years Considered
Figure 10. Global T-cells Leukemia Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global T-cells Leukemia Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global T-cells Leukemia Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global T-cells Leukemia Treatment Market Share by Players in 2019
Figure 15. Global Top T-cells Leukemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T-cells Leukemia Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by T-cells Leukemia Treatment Revenue in 2019
Figure 17. North America T-cells Leukemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe T-cells Leukemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Asia-Pacific T-cells Leukemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. BioCryst Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 21. BioCryst Pharmaceuticals Revenue Growth Rate in T-cells Leukemia Treatment Business (2015-2020)
Figure 22. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. Celgene Revenue Growth Rate in T-cells Leukemia Treatment Business (2015-2020)
Figure 24. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. GlaxoSmithKline Revenue Growth Rate in T-cells Leukemia Treatment Business (2015-2020)
Figure 26. Kirin Holdings Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Kirin Holdings Revenue Growth Rate in T-cells Leukemia Treatment Business (2015-2020)
Figure 28. Otsuka Holdings Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Otsuka Holdings Revenue Growth Rate in T-cells Leukemia Treatment Business (2015-2020)
Figure 30. Mundipharma International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Mundipharma International Revenue Growth Rate in T-cells Leukemia Treatment Business (2015-2020)
Figure 32. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Novartis Revenue Growth Rate in T-cells Leukemia Treatment Business (2015-2020)
Figure 34. Bottom-up and Top-down Approaches for This Report
Figure 35. Data Triangulation
Figure 36. Key Executives Interviewed